Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data-Reference-Cited by-同舟云学术

Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data

Published:2021-01-25 Issue:4 Volume:20 Page:489-497
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Almutairi Abdulaali R.¹²,Erstad Brian L.¹³,McBride Ali¹⁴,Slack Marion¹³,Abraham Ivo¹³⁴⁵^ORCID

Affiliation:

1. Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA

2. Drug sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia

3. Department of Pharmacy Practice and Science, University of Arizona, Tucson, AZ, USA

4. University of Arizona Cancer Center, Tucson, AZ, USA

5. Department of Family and Community Medicine, University of Arizona, Tucson, AZ, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1877272

Reference34 articles.

1. Cancer statistics, 2020

2. Advances in the Management of Melanoma

3. Immune checkpoint inhibitors in melanoma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between toxicity and efficacy of immune checkpoint inhibitors in older adults with NSCLC;Immunotherapy;2024-09-13

2. Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review;Journal of Clinical Medicine;2023-08-07